NexgenRX Inc. Cash Flow Quality Index
NexgenRX Inc. cash flow quality index. NexgenRX Inc. (NXG) has a Cash Flow Quality Index of 1.49x as of September 2025. Operating cash flow of CA$880.82K exceeds net income of CA$589.78K, indicating high earnings quality where cash backs reported profits. See NXG financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of NexgenRX Inc. (2013–2024)
Cash flow quality index of NexgenRX Inc. from 2013 to 2024. Historical Cash Flow Quality Index for NexgenRX Inc. across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore NXG cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
NexgenRX Inc. Cash Flow Quality Index by Year (2013–2024)
NexgenRX Inc. cash flow quality index by year from 2013 to 2024. Year-by-year earnings quality comparison for NexgenRX Inc.. For the full cash flow conversion analysis, see NXG cash generation efficiency.
| Year | Quality Index | Operating CF (CAD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.87x | CA$1.15 Million | CA$614.57K | ▲ +96.6% |
| 2021 | 0.95x | CA$3.82 Million | CA$4.02 Million | ▼ -24.1% |
| 2020 | 1.25x | CA$2.65 Million | CA$2.12 Million | ▲ +50.1% |
| 2016 | 0.84x | CA$490.96K | CA$587.80K | ▼ -34.3% |
| 2013 | 1.27x | CA$774.08K | CA$608.55K | — |